Sanofi Aventis

Welcome to the 'Sanofi-Aventis' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Sanofi-Aventis'.

Latest blogosphere posts tagged “Sanofi Aventis”

• Ready to rumble: Pfizers generic biotech drug push could pit it against Amgen

  
  DailyFinance — Authority: 782
  Filed under: Company News , Healthcare For years, Pfizer ( PFE ) has been trying to prepare for the "patent cliff" its heading for in 2011. Thats when its cholesterol drug Lipitor -- the biggest-selling drug ever with $12 billion in annual sales -- will fall off the rolls of protected drugs. Mindful of that date, ...
  11 hours ago

• (REGN) Regeneron Pharmaceuticals to Expand Research Positions

  
  Stock Blog Hub — Authority: 459
  Regeneron Pharmaceuticals Inc. ( REGN ) announced recently that is investing $40 million, which will result in the creation of up to 100 jobs in East Greenbush facility in Rensselaer County, coupled with another 300 jobs at its Westchester County facility, both in New York. The new positions will be created primarily ...
  1 day ago

• Impactiviti Daily 121009

  
  Impactiviti blog — Authority: 117
  TODAY’S NEWS So…is Roche ’s Tamiflu really that effective? – The effectiveness of Roche Holding AG’s Tamiflu in treating flu complications in healthy adults can’t be determined because the Swiss drugmaker wouldn’t supply data from eight studies, an independent research group said … more The ...
  1 day ago

• Ten stocks for 2010

  
  DailyFinance — Authority: 782
  Filed under: Investing , GlaxoSmithKline By many measures, this past decade was a downer. We experienced the dot-com bust, terrorism attacks, the Enron scandal, Bernie Madoffs Ponzi scheme, at least two wars and the Jonas Brothers. Oh, and lest I forget, one of worst financial crises in history. For anyone ...
  1 day ago

• Impactiviti Daily 120909

  
  Impactiviti blog — Authority: 117
  TODAY’S NEWS Novartis’ “son of Glivec” (Tasigna) carrying on the family tradition – Novartis has reported result of Tasigna Phase III clinical trial. In the study, Tasigna (nilotinib) demonstrated greater efficacy over Glivec (imatinib) in the treatment of adult patients with newly diagnosed ...
  2 days ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 554
  Hello, everyone. There is a great deal of rain falling on the Pharmalot corporate campus this morning, but the pitter patter does not deter us. After all, there is much to do - the usual pile of deadlines and projects awaits. So as we reach for the traditional cup of stimulation, please join us in meeting another day. ...
  2 days ago

• FIBRILLAZIONE ATRIALE: APPROVATO IL DRONEDARONE

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 150
  Sanofi-aventis ha annunciato che la Commissione Europea ha accordato lautorizzazione per la commercializzazione di dronedarone (compresse da 400 mg) in tutti i 27 Stati Membri dell’Unione Europea. Tale approvazione fa seguito allopinione positiva espressa lo scorso 25 Settembre dal Comitato per i Prodotti ...
  3 days ago

• Pharma Unplugged #2 Layoffs & Bonuses

  
  PharmExec Blog — Authority: 118
  Pharma Unplugged #2— Layoffs & Bonuses Recorded: 12/3/2009 Air Date: 12/7/2009 Host: George Koroneos, Pharm Exec Cohost: Reid Paul, Pharm Rep Magazine Show Notes: This week we discuss: Pfizer’s medical education relationship with the Canadian Medical Association Journalists take FDA to task for ...
  4 days ago

• (CYTR) Good News for CytRx Corporation

  
  Stock Blog Hub — Authority: 459
  CytRx Corp. ( CYTR ) announced that the U.S. Food and Drug Administration (FDA) lifted a clinical hold on its molecular chaperone candidate arimoclomol for treating patients suffering from amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease). The agency accepted a revised trial protocol while removing the ...
  1 week ago

• (LLY) Eli Lilly & Company’s Effient Proves Its Worth

  
  Stock Blog Hub — Authority: 459
  Recently, Eli Lilly & Co.’s ( LLY ) Effient (prasugrel) received a major boost when it was added as a treatment option in two clinical guideline updates. These were for patients receiving percutaneous coronary intervention (PCI) and for patients with ST elevation myocardial infarction (STEMI), or severe heart ...
  1 week ago

• (BAX) Baxter International Gets H1N1 Vaccine Order

  
  Stock Blog Hub — Authority: 459
  Baxter International Inc. ( BAX ) recently received another order for 10,000 H1N1 vaccines, commonly known as “swine flu,” from Slovenia. The order is worth $158,700 (105,000 euros). It is estimated that the number of vaccines ordered is sufficient to cover 5,000 people in the country. Slovenia has also decided ...
  1 week ago

• (SNY) Sanofi-Aventis’ Multaq Drug Gains European Commission Approval

  
  Stock Blog Hub — Authority: 459
  Sanofi-Aventis ( SNY ) received good news recently with the company gaining approval from the European Commission for its atrial fibrillation drug, Multaq. The product gained approval for use in adult clinically stable patients with a history of, or current non-permanent atrial fibrillation (AF) to prevent recurrence ...
  1 week ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 554
  Hello again, everyone. Some strong winds blew past the Pharmalot corporate campus overnight, but we don’t take that as a symbol of anything in particular. Now, though, the skies are clear and so is our focus. So time to grab a cup of something stimulating and dig in for another day. Have a good one… AstraZeneca ...
  1 week ago

• CBI and Medical Meetings Magazine Announce Agenda for 6th Annual Pharmaceutical Meeting Management Forum

  
  eReleases Press Release Headlines — Authority: 491
  
  1 week ago

• Pharmalot… Pharmalittle… Morning Edition

  
  Pharmalot — Authority: 554
  Hello, everyone. Nice to see you again. The middle of the week is upon us and, of course, this means trudging through those meetings and projects. But we are prepared. A cup of stimulation is already in hand. What about you? As you brace for another day, here are a few items to help you along. We hope it is a good ...
  1 week ago

• Tis the Season To Be Jolly: Not at Sanofi Aventis!

  
  Bio Job Blog — Authority: 418
  Sanofi Aventis asked it entire sales force to remain at home the Monday after Thanksgiving to wait for a phone call to see whether or not they still had jobs. Nice way for the affected employees to spend Thanksgiving, eh? Sanofi-Aventis is laying off an unspecified number of US sales reps, as the firm restructures ...
  1 week ago

• Local drug firm sells tech for $25 million

  
  Richmond BizSense — Authority: 541
  Intelliject, a Richmond-based pharmaceutical company, just closed a $25 million licensing deal with drug maker Sanofi-aventis.
  1 week ago

• Impactiviti Daily 120109

  
  Impactiviti blog — Authority: 117
  Welcome back from Thanksgiving holiday! Can’t believe it’s already December… This will be the only Impactiviti Daily this week, as I am heading down to South Carolina for the graduation of my #2 son (David) from Marine boot camp. TODAY’S NEWS Layoffs. Sanofi reps are apparently getting the news ...
  1 week ago

• Sanofi-Aventis Confirms Sales Force Layoffs

  
  Pharmalot — Authority: 554
  Yet another drugmaker looks to shrink its sales team. The combination of patent cliffs, fewer regulatory approvals and, in some cases, drugs that never make it to market is forcing one company after another to throw sales reps overboard. Sanofi-Aventis, which faces a 2011 patent expiration on its Plavix ...
  1 week ago

• Atrial fibrillation: Dronedarone Approved in the European Union

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 150
  Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the European Commission has granted marketing authorization for dronedarone – 400mg Tablets in all 27 European member states. This approval follows the European Commission positive opinion issued on September 25, 2009 by the Committee for Medicinal ...
  1 week ago

Comments about Sanofi Aventis